4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0001193125-26-390507
Co-Chief Executive Officer sold 30,464 shares at an average $32.19 ($980,504)
From the SEC's structured data for this filing
Trades in this filing
Cohen Joshua B · Co-Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-10 | Sale : show line 1 in the form | −29,545 | $32.16 | $950,040 | 3,614,042 | D |
| 2026-09-10 | Sale : show line 2 in the form | −919 | $33.15 | $30,464 | 3,613,123 | D |
| Open-market sales · 30,464 sh · avg $32.19 · $980,504 | ||||||
Loading xslF345X06/ownership.xml…